Top compounds associated with response to HCCS


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA masitinib GDSC1000 pan-cancer AAC -0.12 0.0001
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA austocystin d CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.12 0.0002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA PDMP CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV